BioSpace News Archive

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Natural Health Trends Corp.

Designation to accelerate Finch’s efforts to provide an effective therapy for patients fighting recurrent C. difficile infection.

Provides Lilly shareholders opportunity for tax-free exchange

Results establish direct linkage between overexpression of NKCC1, a neuronal Na-K-Cl cotransporter, and emergence of spasticity

Pulmatrix, Inc. announced that it has entered into a securities purchase agreement with certain institutional investors, providing for the purchase and sale of 1,706,484 shares of common stock at a price of $1.465 per share in a registered direct offering priced at-the-market, resulting in total gross proceeds of approximately $2.5 million.

Kodiak Sciences Inc. announced that a presentation on its investigational therapy KSI-301 will be made at the Angiogenesis, Exudation, and Degeneration 2019 meeting being held on February 9, 2019 in Miami, FL.

Executive Management to Host Conference Call on February 21, 2019 at 4:30 p.m. ET

OncoSec Medical Incorporated announced that Dan O’Connor, President, Director & Chief Executive Officer, will present a company overview at the BIO CEO & Investor Conference on Monday, February 11, 2019, at 9:00 a.m. ET in New York, NY.

Mini “bear hug” and “lots of love” benefit lifesaving mission of St. Jude

Northwest Biotherapeutics (OTCQB: NWBO) — (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today released the final voting results from the Annual Shareholder Meeting held on February 2, 2019.